May 12 (Reuters) - Spectral Medical Inc EDT.TO -
* Spectral announces first quarter results
* Q1 loss per share c$0.005
* Revenue for three months ended March 31, 2017 was $941,000 compared to $1.062 million for same three month period last year
* Company expects to file fourth and final module of its pma submission to united states food and drug administration in Q2
* Believes has adequate cash on hand to fund regulatory program and operations through end of q1 of 2018
* Company concluded Q1 of 2017 with cash on hand of $3.71 million compared to $5.08 million as of december 31, 2016 Source text for Eikon: ID:nCCN928zMz Further company coverage: EDT.TO